MRI with ferumoxytol: A single center experience of safety across the age spectrum

ConclusionIn our single‐center experience, no serious AEs occurred with the diagnostic use of ferumoxytol across a wide spectrum of age, renal function, and indications. Because of the limited sample size, firm conclusions cannot be drawn about the generalizability of our results. Thus, vigilance and monitoring are recommended to mitigate potential rare adverse reactions. J. Magn. Reson. Imaging 2016.

Source: Journal of Magnetic Resonance Imaging - July 31, 2016 Category: Radiology Authors: Kim ‐Lien Nguyen, Takegawa Yoshida, Fei Han, Ihab Ayad, Brian L. Reemtsen, Isidro B. Salusky, Gary M. Satou, Peng Hu, J. Paul Finn Tags: Original Research Source Type: research